Baig, A.M. “Counting the neurological cost of COVID-19.” Nat Rev Neurol 18, 5–6 (2022)
Baig, A.M. Counting the neurological cost of COVID-19. Nat Rev Neurol 18, 5–6 (2022). https://doi.org/10.1038/s41582-021-00593-7
The neurological deficits caused by COVID-19, which were first reported in the early months of 2020, continue to intrigue neurologists and health-care professionals worldwide. As two new studies highlight, these manifestations are frequent and are expected to increase the burden of morbidity and mortality in the acute and chronic phases of COVID-19.
Refers to Misra, S. et al. Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis. Neurology https://doi.org/10.1212/WNL.0000000000012930 (2021) | Valencia Sanchez, C. et al. Autoimmune encephalitis post-SARS-CoV-2 infection: case frequency, findings, and outcomes. Neurology https://doi.org/10.1212/WNL.0000000000012931 (2021).